ClinicalTrials.govpublic full text
Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant
acute bilineal leukemia, myelodysplastic/myeloproliferative neoplasm, myelodysplastic/myeloproliferative neoplasm, unclassifiable, myeloproliferative neoplasm, recurrent acute biphenotypic leukemia, recurrent acute lymphoblastic leukemia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 226271
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.